RARG and cancer: It is shown that synthetic retinoid WYC‐209 overcomes the limitation of conventional anticancer drugs by activating retinoic acid receptor gamma exit from nucleus to induce tension‐abrogation‐mediated chromatin decondensation and DNA damage to effectively kill malignant tumors.